Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma. | Diagnostics (Basel) | 2023 | 37627888 | PubTator, text mining | PubMed |
| Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis. | Bioengineering (Basel) | 2023 | 37627776 | PubTator, text mining | PubMed |
| Analyzation of the Peripheral Blood Mononuclear Cells Atlas and Cell Communication of Rheumatoid Arthritis Patients Based on Single-Cell RNA-Seq. | J Immunol Res | 2023 | 37600067 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals a microenvironment and an exhaustion state of T/NK cells in acute myeloid leukemia. | Cancer Sci | 2023 | 37591615 | PubTator, text mining | PubMed |
| Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. | JAMA Netw Open | 2023 | 37589977 | PubTator, text mining | PubMed |
| Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin. | J Immunother Cancer | 2023 | 37586774 | PubTator, text mining | PubMed |
| Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells. | Cell Rep Med | 2023 | 37586321 | PubTator, text mining | PubMed |
| DNASE1L3 enhances antitumor immunity and suppresses tumor progression in colon cancer. | JCI Insight | 2023 | 37581941 | PubTator, text mining | PubMed |
| Cux1+ proliferative basal cells promote epidermal hyperplasia in chronic dry skin disease identified by single-cell RNA transcriptomics. | J Pharm Anal | 2023 | 37577389 | PubTator, text mining | PubMed |
| A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin. | J Pharm Anal | 2023 | 37577386 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers of Septic Shock Based on Pathway and Transcriptome Analyses of Immune-Related Genes. | Genet Res (Camb) | 2023 | 37575977 | PubTator, text mining | PubMed |
| Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma. | Front Immunol | 2023 | 37575244 | PubTator, text mining | PubMed |
| Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | 37573361 | PubTator, text mining | PubMed |
| Protein regulator of cytokinesis 1: a potential oncogenic driver. | Mol Cancer | 2023 | 37563591 | PubTator, text mining | PubMed |
| The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis - preliminary report. | Arch Med Sci | 2023 | 37560743 | PubTator, text mining | PubMed |
| Identification of distinct gene co-expression modules and specific hub genes in skin lesions of atopic dermatitis and psoriasis by WGCNA. | FEBS Open Bio | 2023 | 37548115 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells. | Front Immunol | 2023 | 37545491 | PubTator, text mining | PubMed |
| Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis. | iScience | 2023 | 37534129 | PubTator, text mining | PubMed |
| Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade serous carcinoma using single-cell RNA sequencing and GEO gene expression signatures. | Cell Biosci | 2023 | 37525249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=11